Ross McHenry, MD
Gastroenterology · Cincinnati, OHNPI 1720084353
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,440 of the $1,717 with a category attached, or 83.9%. 26 manufacturers reported payments, led by AbbVie at 26.9% of the total. Reporting peaked in 2019 at $660 and has fallen 91.5% since, to $56 in 2023. That places this record below the midpoint for gastroenterology clinicians in OH, where the typical reported total is $2,203.
Across 108 payments — averaging $15.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$461
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$267
- Fujifilm Healthcare Americas Corporation$170
- Takeda Pharmaceuticals U.S.A., Inc.$132
- Daiichi Sankyo Inc.$108
- Bristol Myers Squibb$77
- plus $501 from 20 others
What the payments were for
- Consulting fees$392%
- Food & beverage$1,44084%
- Education$674%
- Gifts$17010%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 38 | $461 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 18 | $267 |
| Fujifilm Healthcare Americas Corporation | 2 | $170 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $132 |
| Daiichi Sankyo Inc. | 5 | $108 |
| Bristol Myers Squibb | 5 | $77 |
| Johnson & Johnson | 1 | $67 |
| Pfizer | 4 | $62 |
| Intercept Pharmaceuticals, Inc. | 2 | $39 |
| Nestle Healthcare Nutrition Inc. | 2 | $37 |
| QOL Medical, LLC | 3 | $34 |
| Lilly USA, LLC | 1 | $30 |
| Ironwood Pharmaceuticals, Inc | 2 | $28 |
| Evoke Pharma, Inc. | 2 | $27 |
| Medtronic | 1 | $26 |
| Merck | 1 | $18 |
| Amgen | 1 | $18 |
| Gilead | 1 | $15 |
| Shire North American Group Inc | 1 | $15 |
| UCB, Inc. | 1 | $13 |
| Ferring Pharmaceuticals Inc. | 1 | $13 |
| Alfasigma USA, Inc. | 1 | $13 |
| Redhill Biopharma Inc. | 1 | $12 |
| Endo Pharmaceuticals Inc. | 1 | $12 |
| Braintree Laboratories, Inc. | 1 | $12 |
| Dova Pharmaceuticals | 1 | $12 |
How this compares
$1,717 in reported general payments places this provider in the 40th percentile of 657 gastroenterology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Cincinnati
- Anita AfzaliCincinnati$798K
- Kara de FeliceCincinnati$427K
- Allan PeckCincinnati$391K
- Ravi RavinuthalaCincinnati$302K
- Robert IsfortCincinnati$162K
- Luis LaraCincinnati$146K
- Vidhya KunnathurCincinnati$96K
- Moamen GabrCincinnati$70K
- Lisa LestinaCincinnati$59K
- Naim AlkhouriWestlake$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.